Skip to main content

Covid-19 slows Germany’s EPR roll-out

The roll out of Germany's electronic patient record (EPR) programme began on January 1st. However implementation of the programme now looks likely to be delayed by the ongoing coronavirus lockdown.

Germany's EPR programme is behind schedule as it is. Field tests have only just started in some states. The majority of GPs, family doctors and specialists cannot make entries into the EPR system. It is likely to be July before Germany has national EPR coverage.

However the coronavirus situation has added an additional barrier to the EPR roll out.

German lawmakers, and the public, have demanded high security standards for the EPR. There have been significant concerns over privacy and the possibility of data loss.

As a result of these concerns, the identity of an individual has to be verified in person at a local branch office of one of the health insurance funds before an EPR for that individual can be activated.

Due to the coronavirus lockdown, branch offices are closed. The health insurance funds are advising their customers to wait until after the lockdown period is ended before attempting to activate the EPR records.

Further reading:

Comments

Popular posts from this blog

Austria develops Smart Covid-19 Test

Austrian low power sensor firm ams AG has received funding from two Austrian Government ministries to develop a smart device to provide accurate testing for Covid-19. The hand held device is directly connected to a "medical data cloud", does not require a laboratory, and can deliver accurate test results within 15 minutes. The two Austrian Government departments funding the new device are the Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK), and the Federal Ministry for Digital and Economic Affairs (BMDW). ams has used the funds to develop a connected, smart version of a lateral flow test (LFT) device. Lateral flow tests are a standard approach for rapid point of care (PoC) testing. LFTs, which are usually analogue devices, are typically intuitive and easy to use, and are subject to strict regulatory requirements. A pregnancy strip test is a typical example of an analogue LFT device. The challenge for ams was threefold: to cre

Heidelberg develops Unsupervised AI for motor disease

Researchers at the universities of Heidelberg in Germany, and Zurich in Switzerland have developed an AI model to detect human motor impairments and determine underlying diseases. The new software is also a test for how effective unsupervised AI behaviour analysis can be in discovering and determining complex disease states. Conventional supervised instrumented movement analysis is time-consuming, potentially subjective, and cost-intensive. It requires prior knowledge of behaviours of interest, and typically a large amount of video frame annotation. There is scope for human annotator bias, with different annotators focusing on different behaviours, while ignoring or minimising others. The researchers have developed uBAM ("unsupervised Behaviour Analysis and Magnification using Deep Learning"). This is a fully automatic, unsupervised diagnostic support system for behaviour analysis. The new system can extract and classify behaviour automatically, with the ability to compar